Growth Metrics

CorMedix (CRMD) Net Cash Flow (2016 - 2025)

CorMedix has reported Net Cash Flow over the past 15 years, most recently at $96.3 million for Q4 2025.

  • Quarterly results put Net Cash Flow at $96.3 million for Q4 2025, up 1695.31% from a year ago — trailing twelve months through Dec 2025 was $105.1 million (up 3528.03% YoY), and the annual figure for FY2025 was $105.1 million, up 3528.03%.
  • Net Cash Flow reached $96.3 million in Q4 2025 per CRMD's latest filing, up from -$109.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $96.3 million in Q4 2025 and bottomed at -$109.9 million in Q3 2025.
  • Median Net Cash Flow over the past 5 years was -$4.4 million (2021), compared with a mean of $5.2 million.
  • The largest annual shift saw Net Cash Flow plummeted 8611.45% in 2023 before it surged 1695.31% in 2025.
  • Over 5 years, Net Cash Flow stood at -$13.0 million in 2021, then soared by 99.15% to -$111121.0 in 2022, then tumbled by 8611.45% to -$9.7 million in 2023, then surged by 155.44% to $5.4 million in 2024, then soared by 1695.31% to $96.3 million in 2025.
  • Business Quant data shows Net Cash Flow for CRMD at $96.3 million in Q4 2025, -$109.9 million in Q3 2025, and $93.0 million in Q2 2025.